Sorry, you need to enable JavaScript to visit this website.

Skip to main content

Search

Patented Technologies to Advance Disease Research

Patented Technologies

Infectious Diseases & Vaccines

Infectious Diseases & Vaccines

The structure of HIV
The structure of HIV

Innovation is the driving force behind our strong research and development pipeline.

With vaccine candidates in preclinical and clinical development, we are supported by a range of patented technologies such as our PER.C6® human cell line technology which could enable faster and more cost-effective discovery, development and production of a range of potentially transformational vaccines and monoclonal antibodies.

 

PER.C6® TechnologyAdVac® Technology
A comprehensive package of tools and know-how based on our PER.C6® human cell line technology. It provides a cost-effective manufacturing system for high-yield, large-scale production of vaccines and monoclonal antibodies. It is especially useful for vaccine manufacturing that requires the production of hard-to-grow viruses and holds the key to making such vaccines affordable for the whole world.A technology based on the development and production of adenovirus vectors (gene carriers). It can be used together with PER.C6® technology to develop recombinant vaccines against life-threatening infectious diseases.